Chemoinformaics analysis of [(1R,2S,5R,8S)-4,4,8-TRIMETHYL-1-TRICYCLO[6.3.1.02,5]DODECANYL] ACETATE
| Molecular Weight | 264.409 | nRot | 1 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 13 |
| Exact Molecular Weight | 264.209 | nRing | 3 |
| Solubility: LogS | -5.011 | nHRing | 0 |
| Solubility: LogP | 4.202 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 48.6642 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.61 |
| Synth | 4.188 |
| Natural Product Likeliness | 2.949 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.868 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.588 |
| MDCK | 0.0000227 |
| BBB | 0.855 |
| PPB | 0.854545 |
| VDSS | 1.604 |
| FU | 0.160649 |
| CYP1A2-inh | 0.092 |
| CYP1A2-sub | 0.727 |
| CYP2c19-inh | 0.322 |
| CYP2c19-sub | 0.934 |
| CYP2c9-inh | 0.109 |
| CYP2c9-sub | 0.414 |
| CYP2d6-inh | 0.036 |
| CYP2d6-sub | 0.851 |
| CYP3a4-inh | 0.301 |
| CYP3a4-sub | 0.394 |
| CL | 12.667 |
| T12 | 0.156 |
| hERG | 0.032 |
| Ames | 0.011 |
| ROA | 0.041 |
| SkinSen | 0.855 |
| Carcinogencity | 0.877 |
| EI | 0.712 |
| Respiratory | 0.95 |
| NR-Aromatase | 0.149 |
| Antiviral | Yes |
| Prediction | 0.619845 |